Clinical trials
Withdrawn Phase 2 Central Nervous System Neoplasms trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
7 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2007 | 1 |
| 2008 | 1 |
| 2009 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Withdrawn | 7 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Jonsson Comprehensive Cancer Center | 2 |
| NYU Langone Health | 2 |
| Duke University | 1 |
| Lisata Therapeutics, Inc. | 1 |
| University of Texas Southwestern Medical Center | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Central Nervous System Neoplasms | 7 |
| Glioblastoma | 4 |
| Gliosarcoma | 4 |
| Astrocytoma | 2 |
| Oligodendroglioma | 2 |
| Adenoma, Acidophil | 1 |
| Adenoma, Basophil | 1 |
| Adenoma, Chromophobe | 1 |
| Burkitt Lymphoma | 1 |
| Choroid Plexus Neoplasms | 1 |
Trials
Showing 1 to 7 of 7. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.